Medical Marketing and Media |
GSK asthma medication to go before FDA panel Thursday
Medical Marketing and Media GSK's struggle is tied to its blockbuster asthma drug Advair. The drugmaker not only had to lower the price of the branded medication before generic competition surfaced, but it has also failed to build a market for its successor line of Ellipta-based … |
View full post on asthma – Google News